May 15, 2025

Periodontitis Emerges as Modifiable Risk Factor for AMD

Inflammatory mediators are shared between the conditions.

Conexiant

May 15, 2025

Visual Difficulty, Falls, and Mortality

Recurrent falls were associated with a nearly 50% increased hazard of mortality.

Conexiant

May 08, 2025

Alkeus Presents Data at ARVO on Oral Gildeuretinol for GA

Data were presented from Alkeus Pharmaceuticals’ phase 2 SAGA clinical study in GA secondary to AMD.

Ophthalmology Management

May 05, 2025

PDS Updates Continue to Reduce Treatment Burden for Patients with nAMD, DME, and DR

These types of improvements are relatively common after initial approval and are the result of optimization as surgical techniques and knowledge evolve.

Conexiant

May 01, 2025

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

Retinal Physician

January 01, 2023

Retinal Fluid Fluctuations in the Treatment of Neovascular AMD

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

April 19, 2024

Dosing Proceeds in GA Study

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

New Retinal Physician

May 01, 2024

Unraveling Green Disease with the Optovue Solix AngioVue Disc Report

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

October 01, 2023

CLINICAL TRIAL DOWNLOAD

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician